BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2142 related articles for article (PubMed ID: 33522893)

  • 1. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
    England JT; Abdulla A; Biggs CM; Lee AYY; Hay KA; Hoiland RL; Wellington CL; Sekhon M; Jamal S; Shojania K; Chen LYC
    Blood Rev; 2021 Jan; 45():100707. PubMed ID: 32425294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].
    Alfaro-Murillo A; Lazo-Paéz G
    Rev Chilena Infectol; 2021 Apr; 38(2):271-278. PubMed ID: 34184718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
    Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
    BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine Storm Syndrome.
    Cron RQ; Goyal G; Chatham WW
    Annu Rev Med; 2023 Jan; 74():321-337. PubMed ID: 36228171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
    Liu JM; Chi J
    Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
    Hakim NN; Chi J; Olazagasti C; Liu JM
    Exp Biol Med (Maywood); 2021 Jan; 246(1):5-9. PubMed ID: 32972235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
    Opoka-Winiarska V; Grywalska E; Roliński J
    BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine storm in severe COVID-19 pneumonia.
    Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
    J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Secondary Hemophagocytic Lymphohistiocytosis (sHLH) and
    Gautam S; Sharma G; Singla S; Garg S
    Front Med (Lausanne); 2022; 9():835421. PubMed ID: 35783658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
    Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
    Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.
    Chu R; van Eeden C; Suresh S; Sligl WI; Osman M; Cohen Tervaert JW
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.
    Amigues I; Pearlman AH; Patel A; Reid P; Robinson PC; Sinha R; Kim AH; Youngstein T; Jayatilleke A; Konig M
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1185-1204. PubMed ID: 33146561
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
    Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
    Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophagocytic syndrome and COVID-19.
    Retamozo S; Brito-Zerón P; Sisó-Almirall A; Flores-Chávez A; Soto-Cárdenas MJ; Ramos-Casals M
    Clin Rheumatol; 2021 Apr; 40(4):1233-1244. PubMed ID: 33389315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women.
    Obuchowska A; Standyło A; Obuchowska K; Kimber-Trojnar Ż; Leszczyńska-Gorzelak B
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic Lymphohistiocytosis in a Patient With Acute Respiratory Distress Syndrome Secondary to SARS-CoV-2 Infection.
    Greco GF; Spreafico F; Di Costanzo D; Pecoriello A; Garuti M; Inglese F; Cervi G; De Donno G; Beccaria M
    J Med Cases; 2020 Oct; 11(10):327-329. PubMed ID: 34434340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019.
    Clark KEN; Nevin WD; Mahungu T; Lachmann H; Singh A
    Clin Infect Dis; 2021 Nov; 73(9):e3110-e3112. PubMed ID: 32985664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 108.